Abstract
OBJECTIVE: Reduction of growth hormone (GH) secretion in obesity probably reflects neuroendocrine and metabolic abnormalities. Even short-term fasting stimulates GH secretion and distinguishes normal from hypopituitary subjects with growth hormone deficiency (GHD). Marked weight loss improves GH secretion in obesity but the effect of fasting is controversial. We studied the effects of a 36 h fasting on the GH/IGF-I axis and metabolic parameters in obesity.
SUBJECTS: We studied nine obese patients (OB; three male and six female; age, 29.2±4.8; range, 18–59 y; body mass index (BMI), 43.4±2.7 kg/m2; WHR, 0.9±0.1). Fifteen normal subjects (NS; eight male and seven female 28.9±0.6, 25–35 y; 21.6±0.4 kg/m2) and 10 adult hypopituitary patients with severe GH deficiency (GHD; seven male and three female; 37.6±2.3, 29–50 y; 24.5±1.0 kg/m2; GH peak<3µg/l after ITT and/or<9µg/l after GHRH+arginine) served as control groups.
STUDY DESIGN: We studied the effects of 36 h fasting on 8 h diurnal mean GH, insulin and glucose concentrations (mGHc, mINSc and mGLUc; assay every 30 min from 8.00 am to 4.00 pm) as well as on IGF-I, IGFBP-3, ALS, IGFBP-1, GHBP and free fatty acid (FFA) levels.
RESULTS: Before fasting, basal IGF-I and ALS levels in OB were similar to those in NS and both were higher (P<0.001) than those in GHD. IGFBP-3 levels in OB were lower (P<0.01) than in NS but higher (P<0.02) than in GHD. GHBP levels in OB and GHD were similar and both were higher (P<0.01) than in NS. Glucose levels were similar in all groups. FFA levels in OB were higher (P<0.01) than in NS but similar to those in GHD. IGFBP-1 in OB were lower (P<0.05) than in NS and GHD which, in turn, were similar. On the other hand, mINSc in OB was higher (P<0.01) than that in NS and GHD which, in turn, were similar. The mGHc in OB was similar to that in NS but only the latter was higher (P<0.05) than in GHD. The individual mGHc in the three groups overlapped. After fasting, IGF-I levels in GHD were unchanged while they decreased in OB (P=NS) as well as in NS (P<0.01). IGFBP-3 and ALS levels did not change. GHBP levels in OB and GHD were unchanged while they increased in NS (P<0.01). Glucose and FFA levels were reduced and increased, respectively, in all groups (P<0.02 and P<0.01). IGFBP-1 increased while mINSc decreased in all groups (P<0.02 and P<0.01); in OB they persisted lower and higher (P<0.01) respectively, than in NS and GHD. Fasting significantly increased mGHc in NS (P<0.001) but not in OB as well as in GHD. Individual mGHc in OB showed persistent overlap with GHD.
CONCLUSIONS: Short-term fasting does not increase GH secretion in obesity and does not distinguish somatotroph function in obese from that in severe GHD adults. Short-term fasting in obesity has attenuated effects on insulin and IGFBP-1 secretion while it normally increases free fatty acids in spite of any change in GH secretion.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Veldhuis JD, Iranmanesh A, Ho KK, Waters MJ, Johnson ML, Lizarralde G . Dual defects in pulsatile growth hormone secretion and clearance subserve the hyposomatotropism of obesity in man J Clin Endocrinol Metab 1991 72: 51–59.
Cordido F, Penalva A, Dieguez C, Casanueva FF . Massive growth hormone (GH) discharge in obese subjects after the combined administration of GH-releasing hormone and GHRP-6: evidence for a marked somatotroph secretory capability in obesity J Clin Endocrinol Metab 1993 76: 819–823.
Maccario M, Valetto MR, Savio P, Aimaretti G, Baffoni C, Procopio M, Grottoli S, Oleandri SE, Arvat E, Ghigo E . Maximal secretory capacity of somatotrope cells in obesity: comparison with GH deficiency Int J Obes Relat Metab Disord 1997 21: 27–32.
Berelowitz M, Finkelstein JA, Thominet JL, Ting NC, Hirth J, Frohman LA . Impaired growth hormone secretion in spontaneous experimental obesity: a result of increased somatostatin (SRIF) tone 64th Annual meeting of the Endocrine Society San Antonio, TX 1983 84 (abstract 16)
Tannenbaum GS, Epelbaum J, Videau C, Dubuis JM . Sex-related alterations in hypothalamic growth hormone-releasing hormone mRNA-but not somatostatin mRNA-expressing cells in genetically obese Zucker rats Neuroendocrinology 1996 64: 186–193.
Ahmad I, Finkelstein JA, Downs TR, Frohman LA . Obesity-associated decrease in growth hormone-releasing hormone gene expression: a mechanism for reduced growth hormone mRNA levels in genetically obese Zucker rats Neuroendocrinology 1993 58: 332–337.
Frystyk J, Vestbo E, Skjaerbaek C, Mogensen CE, Orskov H . Free insulin-like growth factors in human obesity Metabolism 1995 44 (10 Suppl 4): 37–44.
Melmed S . Insulin suppresses growth hormone secretion by rat pituitary cells J Clin Invest 1984 73: 1425–1433.
Carro E, Senaris R, Considine RV, Casanueva FF, Dieguez C . Regulation of in vivo growth hormone secretion by leptin Endocrinology 1997 138: 2203–2206.
Maccario M, Procopio M, Grottoli S, Oleandri SE, Boffano GM, Taliano M, Camanni F, Ghigo E . Effects of acipimox, an antilipolytic drug, on the growth hormone (GH) response to GH-releasing hormone alone or combined with arginine in obesity Metabolism 1996 45: 342–346.
Dieguez C, Carro E, Seoane LM, Garcia M, Camina JP, Senaris R, Popovic V, Casanueva FF . Regulation of somatotroph cell function by the adipose tissue Int J Obes Relat Metab Disord 2000 24 (Suppl 2): S100–S103.
Ho KY, Veldhuis JD, Johnson ML, Furlanetto R, Evans WS, Alberti KG, Thorner MO . Fasting enhances growth hormone secretion and amplifies the complex rhythms of growth hormone secretion in man J Clin Invest 1988 81: 968–975.
Hartman ML, Veldhuis JD, Johnson ML, Lee MM, Alberti KG, Samojlik E, Thorner MO . Augmented growth hormone (GH) secretory burst frequency and amplitude mediate enhanced GH secretion during a two-day fast in normal men J Clin Endocrinol Metab 1992 74: 757–765.
Thomas GB, Cummins JT, Francis H, Sudbury AW, McCloud PI, Clarke IJ . Effect of restricted feeding on the relationship between hypophysial portal concentrations of growth hormone (GH)-releasing factor and somatostatin, and jugular concentrations of GH in ovariectomized ewes Endocrinology 1991 128: 1151–1158.
Maccario M, Grottoli S, Procopio M, Oleandri SE, Rossetto R, Gauna C, Arvat E, Ghigo E . The GH/IGF-I axis in obesity: influence of neuro-endocrine and metabolic factors. (Review.) Int J Obes Relat Metab Disord 2000 24 (Suppl 2): S96–99.
Rasmussen MH, Hvidberg A, Juul A, Main KM, Gotfredsen A, Skakkebae NE, Hilsted J . Massive weight loss restores 24-hour growth hormone release profiles and serum insulin-like growth factor-I levels in obese subjects J Clin Endocrinol Metab 1995 80: 1407–1415.
Kelijman M, Frohman LA . Enhanced growth hormone (GH) responsiveness to GH-releasing hormone after dietary manipulation in obese and nonobese subjects J Clin Endocrinol Metab 1988 66: 489–495.
Procopio M, Maccario M, Grottoli S, Oleandri SE, Boffano GM, Camanni F, Ghigo E . Short-term fasting in obesity fails to restore the blunted GH responsiveness to GH-releasing hormone alone or combined with arginine Clin Endocrinol 1995 43: 665–669.
Aimaretti G, Colao A, Corneli G, Pivonello R, Maccario M, Morrison K, Pflaum CD, Strasburger CJ, Lombardi G, Ghigo E . The study of spontaneous GH secretion after 36-h fasting distinguishes between GH-deficient and normal adults Clin Endocrinol (Oxf) 1999 51: 771–777.
Carlsson LM, Rowland AM, Clark RG, Gesundheit N, Wong WL . Ligand-mediated immunofunctional assay for quantitation of growth hormone-binding protein in human blood J Clin Endocrinol Metab 1991 73: 1216–1223.
Pflaum CD, Dressendorfer RA, Strasburger CJ . A non isotopic solid phase immunoassay for the determination of growth hormone binding protein (hGHBP) Exp Clin Endocrinol 1993 101 (Suppl 1): 44.
Rowlinson SW, Behncken SN, Rowland JE, Clarkson RW, Strasburger CJ, Wu Z, Baumbach W, Waters MJ . Activation of chimeric and full-length growth hormone receptors by growth hormone receptor monoclonal antibodies. A specific conformational change may be required for full-length receptor signaling J Biol Chem 1998 273: 5307–5314.
Riedel M, Hoeft B, Blum WF, von zur Muhlen A, Brabant G . Pulsatile growth hormone secretion in normal-weight and obese men: differential metabolic regulation during energy restriction Metabolism 1995 44: 605–610.
Clemmons DR, Klibanski A, Underwood LE, McArthur JW, Ridgway EC, Beitins IZ, Van Wyk JJ . Reduction of plasma immunoreactive somatomedin C during fasting in humans J Clin Endocrinol Metab 1981 53: 1247–1250.
Sjogren K, Liu JL, Blad K, Skrtic S, Vidal O, Wallenius V, LeRoith D, Tornell J, Isaksson OJP, Jansson JO, Ohlsson C . Liver-derived insulin-like growth factor-I (IGF-I) is the principal source of IGF-I in blood but is not required for postnatal body growth in mice Proc Natl Acad Sci 1999 96: 7088–7092.
Maccario M, Tassone F, Gianotti L, Lanfranco F, Grottoli S, Arvat E, Muller EE, Ghigo E . Effects of recombinant human insulin-like growth factor I administration on the growth hormone (GH) response to GH-releasing hormone in obesity J Clin Endocrinol Metab 2001 86: 167–171.
Hartman ML, Clayton PE, Johnson ML, Celniker A, Perlman AJ, Alberti KG, Thorner MO . A low dose euglycemic infusion of recombinant human insulin-like growth factor I rapidly suppresses fasting-enhanced pulsatile growth hormone secretion in humans J Clin Invest 1993 91: 2453–2462.
Hoffman DM, O'Sullivan AJ, Baxter RC, Ho KK . Diagnosis of growth-hormone deficiency in adults Lancet 1994 343: 1064–1068.
Nam SY, Lee, Kim KR, Lee HC, Nam MS, Cho JH, Huh KB . Long-term administration of acipimox potentiates growth hormone response to growth hormone-releasing hormone by decreasing serum free fatty acid in obesity Metabolism 1996 45: 594–597.
Diamond MP, Hallarman L, Starick-Zych K, Jones TW, Connoly-Howard M, Tamborlane W, Sherwin RS . Suppression of counterregulatory hormone response to hypoglycemia by insulin per se J Clin Endocrinol Metab 1991 72: 1388–1390.
Casanueva FF, Dieguez C . Interaction between body composition, leptin and growth hormone status Baillières Clin Endocrinol Metab 1998 12: 297–314.
Alvarez CV, Mallo F, Burguera B, Cacicedo L, Dieguez C, Casanueva FF . Evidence for a direct pituitary inhibition by free fatty acids of in vivo growth hormone responses to growth hormone-releasing hormone in the rat Neuroendocrinology 1991 53: 185–189.
Conover CA, Lee PD, Kanaley JA, Clarkson JT, Jensen MD . Insulin regulation of insulin-like growth factor binding protein-I in obese and nonobese humans J Clin Endocrinol Metab 1992 74: 1355–1360.
Yamashita S, Melmed S . Effect of insulin on rat anterior pituitary cells Diabetes 1986 35: 440–447.
Klein S, Horowitz JF, Landt M, Goodrick SJ, Mohamed-Ali V, Coppack SW . Leptin production during early starvation in lean and obese women Am J Physiol Endocrinol Metab 2000 278: E280–284.
Senaris RM, Lewis MD, Lago F, Dominguez F, Scanlon MF, Dieguez C . Effects of free fatty acids on somatostatin secretion, content and mRNA levels in cortical and hypothalamic fetal rat neurones in monolayer culture J Mol Endocrinol 1993 10: 207–214.
Cordido F, Fernandez T, Martinez T, Penalva A, Peino R, Casanueva FF, Dieguez C . Effect of acute pharmacological reduction of plasma free fatty acids on growth hormone (GH) releasing hormone-induced GH secretion in obese adults with and without hypopituitarism J Clin Endocrinol Metab 1998 83: 4350–4354.
Horowitz JF, Coppack SW, Paramore D, Cryer PE, Zhao G, Klein S . Effect of short-term fasting on lipid kinetics in lean and obese women Am J Physiol 1999 276: E278–284.
Frystyk J, Delhanty PJ, Skjaerbaek C, Baxter RC . Changes in the circulating IGF system during short-term fasting and refeeding in rats Am J Physiol 1999 277: E245–252.
Bang P, Brismar K, Rosenfeld RG, Hall K . Fasting affects serum insulin-like growth factors (IGFs) and IGF-binding proteins differently in patients with noninsulin-dependent diabetes mellitus versus healthy nonobese and obese subjects J Clin Endocrinol Metab 1994 78: 960–967.
Acknowledgements
This work was partially supported by the grant 9906153187 from Ministero Universitá e Ricerca Scientifica Tecnologica, Rome, Italy and by Fondazione Studio Malattie Endocrino-Metaboliche, Turin, Italy. The authors wish to thank Professor F Camanni and Drs C Ganzaroli, SE Oleandri, M Procopio, M Bidlingmaier, K Morrison and CD Pflaum for their cooperation in the study and S Freihofer, R Schwaiger and M Taliano for their skilful technical assistance.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Maccario, M., Aimaretti, G., Grottoli, S. et al. Effects of 36 hour fasting on GH/IGF-I axis and metabolic parameters in patients with simple obesity. Comparison with normal subjects and hypopituitary patients with severe GH deficiency. Int J Obes 25, 1233–1239 (2001). https://doi.org/10.1038/sj.ijo.0801671
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.ijo.0801671
Keywords
This article is cited by
-
Effects of short-term fasting on cancer treatment
Journal of Experimental & Clinical Cancer Research (2019)
-
The effects of short-term fasting on tolerance to (neo) adjuvant chemotherapy in HER2-negative breast cancer patients: a randomized pilot study
BMC Cancer (2015)
-
Fasting vs dietary restriction in cellular protection and cancer treatment: from model organisms to patients
Oncogene (2011)
-
Growth hormone receptor modulators
Reviews in Endocrine and Metabolic Disorders (2009)
-
The effects of a high-fruit and -vegetable, high-fiber, low-fat dietary intervention on serum concentrations of insulin, glucose, IGF-I and IGFBP-3
European Journal of Clinical Nutrition (2008)